Distribution of the Number of Questions Answered Correctly (Cardiologists n = 586)

Slides:

Advertisements

Similar presentations

Summary Prepared by Melvyn Rubenfire, MD

Advertisements

The ABC’s of the AHA/ACC Prevention Guidelines

NCEP ATP IV GuidelineS: 2013 Update

1 Guidelines Applied to Practice (GAP) American College of Cardiology, Puerto Rico Chapter.

Protecting the heart and the kidney: Implications from the SHARP trial Dr. Christina Reith University of Oxford United Kingdom.

Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-

Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.

Glucose – Insulin – Potassium Study in Patients with ST Elevation Myocardial Infarction without Signs of Heart Failure Presented at American College of.

Hmmmm… … What is Cardiology What is Cardiology? Cardiologists are doctors specially trained in treating problems involved in the heart. For example,

This presentation reflects the views of the presenter and does not necessarily reflect the views of the American College of Cardiology Content Distributed.

Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.

Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings PowerPoint® Lectures Lectures by Chris Romero, Front Range Community College Rebuilding.

Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.

Rimonabant in Obesity Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Jean-Pierre Despres RIO LIPIDS Trial.

Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty Study (ARMYDA-2) Trial ARMYDA-2 Trial Presented at The American College of Cardiology.

Antithrombotic Trialists’ (ATT) Collaboration. Lancet 2009;373:

WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

Cancer Facts and Figures Information and Guidelines.

The SHAPE Trial Advisory Meeting – Part II GoToMeeting Session Monday Nov 9 th, 12PM EST Dial +1 (312)

ACC/AHA Guidelines Not the Final or Only Word. Contemporary Guidelines

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Primary Prevention of Cardiovascular Mortality and.

Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis.

Update in Cardiology A Cardiologist’s Eye for the Primary Guy Abdul H Sankari Heartland Cardiovascular Center.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Proposal to Incorporate Trial Data Into a Hybrid.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.

How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.

Journal Club Benjamin Han June 7th, 2013.

Copyright © 2012 American Medical Association. All rights reserved.

Copyright © 2011 American Medical Association. All rights reserved.

The Rise and Fall of Hormone Replacement Therapy

Ann Intern Med. 2009;150(11): doi: / Figure Legend:

From: Quantitative Synthesis in Systematic Reviews

Pravastatin in Elderly Individuals at Risk of Vascular Disease

Cholesterol practice questions

From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2013;159(10):

Achieving the Clinical Potential of RAAS Blockade

Selection of NSAIDs for Osteoarthritis

NAPLEX preparation: Biostatistics

A multicenter, double-blind, randomized study to establish the clinical benefit and safety of ezetimibe/simvastatin tablet (vytorin) vs simvastatin.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery Stephen.

Irbedrin Group Training

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

NOACS: Emerging data in ACS/IHD

Dean J. Kereiakes et al. JACC 2017;70:

Aspirin in the prevention of cancer – Author's reply

This series of slides highlights a report based on a presentation at the Late-Breaking Trial Sessions of the 2005 American Heart Association Scientific.

Section III: Neurohormonal strategies in heart failure

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta- analysis of individual participant data from randomised trials

Wesley T. O’Neal et al. JACEP 2016;2:

The Potential Effects of Implementing the 2013 ACC/AHA Cholesterol Guidelines on the Use of Statins in a Large Health Maintenance Organization in Israel

Originally presented by Drs. Daniel Levy, Richard H. Grimm, Steven E

Contemporary Evidence-Based Guidelines

These slides highlight a presentation from a Special Session of the Late-Breaking Clinical Trials sessions during the American College of Cardiology 2005.

Khurram Nasir et al. JACC 2015;66:

ARISE Trial Aggressive Reduction of Inflammation Stops Events

Figure 1 Relationships between magnitude of antithrombotic benefit vs

The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any type of cancer) to reduce all-cause mortality compared.

Maria R. Costanzo et al. JCHF 2016;4:

Published online Feb 7, 2019 Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling:

CAPP2: Time to first colorectal cancer in those randomized to aspirin compared with those randomized to the aspirin placebo. CAPP2: Time to first colorectal.

Potential effect of guidelines on ASCVD prevention in the CGPS*

Requested Information by CMS Team During April 30th Hearing

Do meta-analyses in nephrology change the way we treat patients?

Section C: Clinical trial update: Oral antiplatelet therapy

Gianluigi Savarese et al. JCHF 2016;4:

Presentation transcript:

Distribution of the Number of Questions Answered Correctly (Cardiologists n = 586)

Which of the following statements is true?

Guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA) recommend low-dose aspirin for individuals with a __ 3-year risk of coronary heart disease or a ___ 10-year risk of coronary heart disease:

The 2009 ATTC meta-analysis of 6 primary prevention trials showed that the use of long-term aspirin was associated with which of the following results?

Meta-analyses have shown daily aspirin use to:

Pooled analyses of randomized controlled trials have shown that daily aspirin use can:

What do published analyses of aspirin use and colon cancer risk reduction suggest?

Colorectal Adenoma/Carcinoma Prevention Programme (CAPP) 2

CAPP2 Follow up Data May 2013

By what percentage can daily aspirin use reduce the 20-year risk of death from colorectal cancer?